Zucara Therapeutics, Inc.
🇨🇦Canada
- Country
- 🇨🇦Canada
- Ownership
- Holding
- Established
- 2015-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.zucara.ca
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Phase 2
Recruiting
- Conditions
- Type 1 Diabetes Mellitus with Hypoglycemia
- Interventions
- Drug: PlaceboDrug: ZT-01, 7 mgDrug: ZT-01, 22 mgDrug: ZT-01, 15 mg
- First Posted Date
- 2023-03-09
- Last Posted Date
- 2025-03-11
- Lead Sponsor
- Zucara Therapeutics Inc.
- Target Recruit Count
- 186
- Registration Number
- NCT05762107
- Locations
- 🇺🇸
Headlands Research, Escondido, California, United States
🇺🇸USC Keck Medicine Eastside Center for Diabetes, Los Angeles, California, United States
🇺🇸LCGK Research, San Carlos, California, United States
Effect of ZT-01 on Glucagon During Hypoglycemia in Type 1 Diabetes Mellitus
Phase 1
Terminated
- Conditions
- HypoglycemiaType 1 Diabetes
- Interventions
- Drug: ZT-01 low doseDrug: ZT-01 high doseDrug: Placebo
- First Posted Date
- 2021-08-17
- Last Posted Date
- 2023-07-12
- Lead Sponsor
- Zucara Therapeutics Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT05007977
- Locations
- 🇨🇦
LMC Manna Research, Toronto, Ontario, Canada
© Copyright 2025. All Rights Reserved by MedPath